
    
      In this study patients with chronic renal insufficiency and secondary osteoporosis or bone
      loss will be evaluated with traditional Chinese medicine standard and allocated into kidney
      Yin deficiency and kidney Yang deficiency groups. In Yin deficiency group, patients will be
      divided into Zuogui granules treatment group and placebo group. In Yang deficiency group,
      patients will be divided into Yuogui granules treatment group and placebo group. All the
      patients will also accept basic treatment.

      After 3-month-treatment, we will detect blood urea nitrogen, creatinine, bone mineral
      density, bone metabolism markers including FGF23, 1,25(OH)2D3, Osteocalcin, PTH, BALP, serum
      and urinal Ca, P. We will also perform miRNA array. The data before treatment and after
      treatment will be compared. The data of treatment groups and placebo groups will also be
      compared.
    
  